{"count": 12, "results": [{"_id": "7408390", "pmid": 7408390, "title": "Atenolol kinetics in renal failure.", "journal": "Clin Pharmacol Ther", "authors": ["McAinsh J", "Holmes BF", "Smith S", "Hood D", "Warren D"], "date": "1980-09-01T00:00:00Z", "doi": "10.1038/clpt.1980.166", "meta_date_publication": "1980 Sep", "meta_volume": "28", "meta_issue": "3", "meta_pages": "302-9", "score": 50091.652, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ kinetics in @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@renal failure@@@.", "citations": {"NLM": "McAinsh J, Holmes BF, Smith S, Hood D, Warren D. Atenolol kinetics in renal failure. Clin Pharmacol Ther. 1980 Sep;28(3):302-9. PMID: 7408390", "BibTeX": "@article{7408390, title={Atenolol kinetics in renal failure.}, author={McAinsh J and Holmes BF and Smith S and Hood D and Warren D}, journal={Clin Pharmacol Ther}, volume={28}, number={3}, pages={302-9}}"}}, {"_id": "3751021", "pmid": 3751021, "title": "Atenolol overdosage in a patient with progressive renal failure.", "journal": "West J Med", "authors": ["Giang DW", "Isaeff DM"], "date": "1986-07-01T00:00:00Z", "meta_date_publication": "1986 Jul", "meta_volume": "145", "meta_issue": "1", "meta_pages": "101-3", "score": 50081.484, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ overdosage in a @SPECIES_9606 @@@patient@@@ with progressive @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@renal failure@@@.", "citations": {"NLM": "Giang DW, Isaeff DM. Atenolol overdosage in a patient with progressive renal failure. West J Med. 1986 Jul;145(1):101-3. PMID: 3751021", "BibTeX": "@article{3751021, title={Atenolol overdosage in a patient with progressive renal failure.}, author={Giang DW and Isaeff DM}, journal={West J Med}, volume={145}, number={1}, pages={101-3}}"}}, {"_id": "7378254", "pmid": 7378254, "title": "Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis.", "journal": "Br J Clin Pharmacol", "authors": ["Flouvat B", "Decourt S", "Aubert P", "Potaux L", "Domart M", "Goupil A", "Baglin A"], "date": "1980-04-01T00:00:00Z", "doi": "10.1111/j.1365-2125.1980.tb01065.x", "meta_date_publication": "1980 Apr", "meta_volume": "9", "meta_issue": "4", "meta_pages": "379-85", "score": 50077.03, "text_hl": "Pharmacokinetics of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@terminal renal failure@@@ and influence of haemodialysis.", "citations": {"NLM": "Flouvat B, Decourt S, Aubert P, Potaux L, Domart M, Goupil A, Baglin A. Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis. Br J Clin Pharmacol. 1980 Apr;9(4):379-85. PMID: 7378254", "BibTeX": "@article{7378254, title={Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis.}, author={Flouvat B and Decourt S and Aubert P and Potaux L and Domart M and Goupil A and Baglin A}, journal={Br J Clin Pharmacol}, volume={9}, number={4}, pages={379-85}}"}}, {"_id": "6749509", "pmid": 6749509, "title": "Clinical pharmacokinetics of atenolol--a review.", "journal": "Eur J Drug Metab Pharmacokinet", "authors": ["Kirch W", "Görg KG"], "date": "1982-01-01T00:00:00Z", "doi": "10.1007/BF03188723", "meta_date_publication": "1982", "meta_volume": "7", "meta_issue": "2", "meta_pages": "81-91", "score": 50069.36, "text_hl": "Prolongation of elimination half life requires a dosage adjustment of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@renal failure@@@. ", "citations": {"NLM": "Kirch W, Görg KG. Clinical pharmacokinetics of atenolol--a review. Eur J Drug Metab Pharmacokinet. 1982;7(2):81-91. PMID: 6749509", "BibTeX": "@article{6749509, title={Clinical pharmacokinetics of atenolol--a review.}, author={Kirch W and Görg KG}, journal={Eur J Drug Metab Pharmacokinet}, volume={7}, number={2}, pages={81-91}}"}}, {"_id": "15218321", "pmid": 15218321, "title": "Oxidative stress status in kidney tissue after losartan and atenolol treatment in experimental renal failure.", "journal": "Nephron Exp Nephrol", "authors": ["Pechter U", "Aunapuu M", "Riispere Z", "Vihalemm T", "Kullissaar T", "Zilmer K", "Zilmer M", "Ots M"], "date": "2004-01-01T00:00:00Z", "doi": "10.1159/000078404", "meta_date_publication": "2004", "meta_volume": "97", "meta_issue": "2", "meta_pages": "e33-7", "score": 50067.453, "text_hl": "Oxidative stress status in kidney tissue after @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ treatment in experimental @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@renal failure@@@.", "citations": {"NLM": "Pechter U, Aunapuu M, Riispere Z, Vihalemm T, Kullissaar T, Zilmer K, Zilmer M, Ots M. Oxidative stress status in kidney tissue after losartan and atenolol treatment in experimental renal failure. Nephron Exp Nephrol. 2004;97(2):e33-7. PMID: 15218321", "BibTeX": "@article{15218321, title={Oxidative stress status in kidney tissue after losartan and atenolol treatment in experimental renal failure.}, author={Pechter U and Aunapuu M and Riispere Z and Vihalemm T and Kullissaar T and Zilmer K and Zilmer M and Ots M}, journal={Nephron Exp Nephrol}, volume={97}, number={2}, pages={e33-7}}"}}, {"_id": "6487486", "pmid": 6487486, "title": "Atenolol pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.", "journal": "Br J Clin Pharmacol", "authors": ["Salahudeen AK", "Wilkinson R", "McAinsh J", "Bateman DN"], "date": "1984-09-01T00:00:00Z", "doi": "10.1111/j.1365-2125.1984.tb02490.x", "meta_date_publication": "1984 Sep", "meta_volume": "18", "meta_issue": "3", "meta_pages": "457-60", "score": 50064.8, "text_hl": "...The elimination of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ (20 mg i.v.) has been studied in seven @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@renal failure@@@ on continuous ambulatory peritoneal dialysis (CAPD). ", "citations": {"NLM": "Salahudeen AK, Wilkinson R, McAinsh J, Bateman DN. Atenolol pharmacokinetics in patients on continuous ambulatory peritoneal dialysis. Br J Clin Pharmacol. 1984 Sep;18(3):457-60. PMID: 6487486", "BibTeX": "@article{6487486, title={Atenolol pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.}, author={Salahudeen AK and Wilkinson R and McAinsh J and Bateman DN}, journal={Br J Clin Pharmacol}, volume={18}, number={3}, pages={457-60}}"}}, {"_id": "10928688", "pmid": 10928688, "title": "Treatment of atenolol overdose in a patient with renal failure using serial hemodialysis and hemoperfusion and associated echocardiographic findings.", "journal": "Vet Hum Toxicol", "authors": ["Salhanick SD", "Wax PM"], "date": "2000-08-01T00:00:00Z", "meta_date_publication": "2000 Aug", "meta_volume": "42", "meta_issue": "4", "meta_pages": "224-5", "score": 50064.586, "text_hl": "Treatment of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ @DISEASE_Drug_Overdose @DISEASE_MESH:D062787 @@@overdose@@@ in a @SPECIES_9606 @@@patient@@@ with @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@renal failure@@@ using serial hemodialysis and hemoperfusion and associated echocardiographic findings.", "citations": {"NLM": "Salhanick SD, Wax PM. Treatment of atenolol overdose in a patient with renal failure using serial hemodialysis and hemoperfusion and associated echocardiographic findings. Vet Hum Toxicol. 2000 Aug;42(4):224-5. PMID: 10928688", "BibTeX": "@article{10928688, title={Treatment of atenolol overdose in a patient with renal failure using serial hemodialysis and hemoperfusion and associated echocardiographic findings.}, author={Salhanick SD and Wax PM}, journal={Vet Hum Toxicol}, volume={42}, number={4}, pages={224-5}}"}}, {"_id": "4064783", "pmid": 4064783, "title": "Marked suppression of ventilation while awake following massive ingestion of atenolol.", "journal": "Chest", "authors": ["Montgomery AB", "Stager MA", "Schoene RB"], "date": "1985-12-01T00:00:00Z", "doi": "10.1378/chest.88.6.920", "meta_date_publication": "1985 Dec", "meta_volume": "88", "meta_issue": "6", "meta_pages": "920-1", "score": 50062.227, "text_hl": "Although we are unable to prove a causal relationship, future @SPECIES_9606 @@@patients@@@ with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ @DISEASE_Drug_Overdose @DISEASE_MESH:D062787 @@@overdose@@@ should be observed carefully for @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@ventilatory failure@@@, even if fully conscious.", "citations": {"NLM": "Montgomery AB, Stager MA, Schoene RB. Marked suppression of ventilation while awake following massive ingestion of atenolol. Chest. 1985 Dec;88(6):920-1. PMID: 4064783", "BibTeX": "@article{4064783, title={Marked suppression of ventilation while awake following massive ingestion of atenolol.}, author={Montgomery AB and Stager MA and Schoene RB}, journal={Chest}, volume={88}, number={6}, pages={920-1}}"}}, {"_id": "4003284", "pmid": 4003284, "title": "Hemodynamic effects of nifedipine given alone and in combination with atenolol in patients with impaired left ventricular function.", "journal": "Am J Cardiol", "authors": ["de Buitleir M", "Rowland E", "Krikler DM"], "date": "1985-05-17T00:00:00Z", "doi": "10.1016/0002-9149(85)91206-8", "meta_date_publication": "1985 May 17", "meta_volume": "55", "meta_issue": "12", "meta_pages": "15E-20E", "score": 50059.77, "text_hl": "Chronic oral administration of @CHEMICAL_Nifedipine @CHEMICAL_MESH:D009543 @@@nifedipine@@@ in combination with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ precipitated @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@LV failure@@@ only in those with the lowest EF and highest LVEDP; usually @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@LV failure@@@ was present with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ alone. ", "citations": {"NLM": "de Buitleir M, Rowland E, Krikler DM. Hemodynamic effects of nifedipine given alone and in combination with atenolol in patients with impaired left ventricular function. Am J Cardiol. 1985 May 17;55(12):15E-20E. PMID: 4003284", "BibTeX": "@article{4003284, title={Hemodynamic effects of nifedipine given alone and in combination with atenolol in patients with impaired left ventricular function.}, author={de Buitleir M and Rowland E and Krikler DM}, journal={Am J Cardiol}, volume={55}, number={12}, pages={15E-20E}}"}}, {"_id": "8914031", "pmid": 8914031, "title": "Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy.", "journal": "Kidney Int", "authors": ["Bakris GL", "Copley JB", "Vicknair N", "Sadler R", "Leurgans S"], "date": "1996-11-01T00:00:00Z", "doi": "10.1038/ki.1996.480", "meta_date_publication": "1996 Nov", "meta_volume": "50", "meta_issue": "5", "meta_pages": "1641-50", "score": 50040.95, "text_hl": "Therefore, in persons with @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@renal insufficiency@@@ secondary to @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@NIDDM@@@, similar levels of blood pressure control with either @CHEMICAL_Lisinopril @CHEMICAL_MESH:D017706 @@@lisinopril@@@ or NDCCBs slowed progression of @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@renal disease@@@ to a greater extent than @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@. ", "citations": {"NLM": "Bakris GL, Copley JB, Vicknair N, Sadler R, Leurgans S. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. Kidney Int. 1996 Nov;50(5):1641-50. PMID: 8914031", "BibTeX": "@article{8914031, title={Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy.}, author={Bakris GL and Copley JB and Vicknair N and Sadler R and Leurgans S}, journal={Kidney Int}, volume={50}, number={5}, pages={1641-50}}"}}]}